ARTICLE

FindCenter AddIcon

CIA Exploited Incarcerated Black Americans in Race for “Mind-Control” Agent

By Dana Strauss, Monnica Williams — 2021

A well-kept American secret is that the CIA-funded research that exploited incarcerated Black Americans along with other vulnerable groups in America’s hunt for a “mind-control” drug.

Read on blogs.bmj.com

FindCenter Post-Image

Psychedelics Could Trigger a ‘Paradigm Shift’ in Mental Health Care

A new review of studies finds that LSD, psilocybin, and MDMA hold potential for treating mental illness.

Article
Carolyn Gregoire
2015
FindCenter AddIcon
FindCenter Post-Image

The Return of Psychedelics to Counseling: Are We Ready?

Those of us who are professional counselors are perhaps most likely to recognize psychedelic drugs by their recreational or street names — acid, magic mushrooms, ecstasy — and to consider them to be drugs of abuse that may be dangerous to our clients.

Article
Benjamin Hearn
2020
FindCenter AddIcon
FindCenter Post-Image

Psilocybin Sessions: Psychedelics Could Help People with Addiction and Anxiety

Study participants at some of the country's leading medical research centers are going through intense therapy and six-hour psychedelic journeys deep into their minds to do things like quit smoking and worry less.

Article
Anderson Cooper
2019
FindCenter AddIcon
FindCenter Post-Image

For the First Time, Scientists Have Imaged the Brain on LSD

The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.

Article
Victoria Turk
2016
FindCenter AddIcon
FindCenter Post-Image

Interview with Albert Hofmann, the Man Who First Synthesized LSD

The late chemist Albert Hofmann discussed his psychedelic research on LSD in the July, 1976 issue of High Times.

Article
High Times
2020
FindCenter AddIcon
FindCenter Post-Image

Largest Ever Psychedelics Study Maps Changes of Conscious Awareness to Neurotransmitter Systems

In the world’s largest study on psychedelics and the brain, a team of researchers from The Neuro (Montreal Neurological Institute-Hospital) and Department of Biomedical Engineering of McGill University, the Broad Institute at Harvard/MIT, SUNY Downstate Health Sciences University, and Mila—Quebec...

Article
Neuroscience News
2022
FindCenter AddIcon
FindCenter Post-Image

An Introduction to Psilocybin

With the advent of the psychedelic renaissance occurring currently, many people have become curious about one of the most famous hallucinogens: psilocybin mushrooms. Read on to discover the most important information about these fascinating fungi.

Article
FindCenter
2022
FindCenter AddIcon
FindCenter Post-Image

It’s Time to Start Studying the Downside of Psychedelics

Before psychedelic therapy and services becomes widely available, there needs to be a better understanding of all the ways these experiences can go wrong.

Article
Shayla Love
2022
FindCenter AddIcon
FindCenter Post-Image

FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

Article
Yasemin Saplakoglu
2019
FindCenter AddIcon
FindCenter Post-Image

Ketamine Therapy Is Going Mainstream. Are We Ready?

The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.

Article
Emily Witt
2021
FindCenter AddIcon

EXPLORE TOPIC

LSD